| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2011-01-12 | Vaximm (Germany) | CHF 7.8 million | financing round | BB Biotech Ventures (Switzerland) Merck KGaA (Germany) Sunstone Capital (Denmark) Merck Serono Ventures (Switzerland) BioMedPartners (Switzerland) | Cancer - Oncology | Financing round |
| 2011-01-10 | Polyplus-transfection (France) | € 2,5 million | financing round | AIRFI (Alsace Inter Regio Fonds d’Investissement) (France)Sudinnova (France)CIC Vizille Capital Innovation (France)CIC Finance (France) | Technology - Services | Fundraising |
| 2011-01-06 | Symphogen (Denmark) | €141 million | placement of preferred stock to a group of investors | Novo A/S (Denmark Essex Woodlands (USA-UK) Danish Pension Fund PKA (Denmark) | Cancer - Oncology | Private placement |
| 2010-06-29 | Bind Biosciences (USA - MA) | $23.4 million | series C financing round | DHK Investment (India) Polaris Venture Partners (USA - MA) Flagship Ventures (USA - MA) ARCH Venture Partners (USA - IL) Endeavour Vision (Switzerland) NanoDimension (USA - CA) new private investors | Series C financing round | |
| 0000-00-00 | Oasmia Pharmaceutical (Sweden) | SEK 42 million (€ 4.4 million) | private placement | Cancer - Oncology - Veterinary medicine | Private placement | |
| 0000-00-00 | Inthera Bioscience (Switzerland) | CHF 10.5 Million (€ 9.64 million) | series A financing round | Merck Ventures (Germany) Aglaia BioMedical Ventures (The Netherlands) Novo Seeds (Denmark) | Cancer - Oncology | Series A financing round |
| 0000-00-00 | $6.95 million | grant | National Institute of Allergy and Infectious Diseases (NIAID) (USA) | Infectious diseases | Grant | |
| 0000-00-00 | Iterum Therapeutics (Ireland) | $65 million | series B financing round | Arix Bioscience (UK) Pivotal bioVenture Partners (USA - CA) Bay City Capital (USA - CA) Advent Life Sciences (UK) Domain Associates (USA - NJ) Frazier Healthcare Partners (USA - WA) Canaan Partners (USA - CA) Sofinnova Ventures (USA - CA) New Leaf Venture Partners (USA - CA) | Infectious diseases | Series B financing round |
| 0000-00-00 | ImCheck Therapeutics (France) | € 1 million | subvention | Bpifrance (France) | Cancer - Oncology | Subvention |
| 0000-00-00 | Restructuring | |||||
| 0000-00-00 | Freeline Therapeutics (UK) | Restructuring |
